October 2, 2026
Pharma marketers have more access than ever to sophisticated HCP audiences. The competitive advantage is shifting to the technology infrastructure that keeps those audiences dynamic and turns CRM activity, media activation, and measurement into accumulated learning.
_______________________________________________________________________________
Two pharma brands can start with essentially the same physician target audience and still operate very different media programs.
One may activate against an NPI-based HCP target list at the beginning of a campaign, run it across multiple channels, and evaluate performance against standard media metrics.
The other may begin with the same HCP universe but continuously refine it based on CRM activity, suppress physicians who have already taken a desired action, vary messaging based on prior engagement, and connect media exposure back to NPI-level outcomes.
The audience is nearly identical. The capability isn’t.
For years, audience access itself was a meaningful advantage in pharma and healthcare marketing. Identifying the right specialists, patients, caregivers, or condition-specific populations required specialized data, technology, and partnerships that were not universally available.
That advantage hasn’t disappeared, but it’s become far less scarce. Healthcare audiences are now available through a growing number of data providers, DSPs, publishers, identity platforms, and healthcare-specific media companies. A marketer looking to reach cardiologists, oncologists, neurologists, endocrinologists, or other specialists treating a particular condition has more options than ever before.
That changes where competitive advantage begins to accumulate. It’s no longer simply who a brand can reach. It’s what happens to that audience before, during, and after media activation.
The Advantage Is Moving Around the Audience
The audience itself is becoming less differentiated while the infrastructure surrounding it becomes more important.
That infrastructure determines whether audience data stays static or becomes dynamic, whether a brand recognizes that a physician who was a prospect three months ago may no longer be one today, and whether campaign learning accumulates over time or resets every time a new agency, technology stack, or operating model enters the picture.
Those differences can look operational on the surface. In practice, they shape media strategy.
Stale Audiences Create Stale Media
Consider audience refresh cadence.
An HCP target list built at the start of a six-month campaign may be accurate on day one, but the commercial environment keeps moving. Physicians engage with representatives, request information, start prescribing, stop prescribing. CRM systems collect new information the media plan never sees.
If none of that changes the audience, the campaign gradually becomes less intelligent even as its optimization gets more sophisticated. The platform may be optimizing bids, placements, and frequency in real time, but against an audience definition that’s months old.
The industry has invested heavily in making media execution dynamic. Audience infrastructure has to become dynamic too.
Audience Suppression Should Change the Media Strategy
Audience suppression is often treated as a technical detail: remove certain users from a campaign and move on. But poor suppression has a strategic cost.
If a physician has already completed the action a campaign was designed to encourage, continuing to serve acquisition-oriented messaging wastes budget and creates a worse experience, and it prevents the strategy from evolving.
Once a physician takes the action a campaign was designed to encourage, the next decision shouldn’t simply be whether to stop serving ads. Their place in the media strategy has changed. Frequency may decline, the message may evolve, or the physician may move into a different stage of communication altogether.
In that sense, suppression is less about removing someone from an audience than recognizing when the relationship has changed.
CRM Data Becomes More Valuable When It Can Change Media
Pharma companies already possess significant customer intelligence. The challenge is rarely the absence of information. It’s the distance between that information and media execution.
A CRM system may know that a physician attended an event, requested information, or moved into a different stage of the brand relationship. But if that information doesn’t meaningfully change the media experience, its value stays trapped inside another system.
That connection should work both ways. Media engagement can inform sales and brand follow-up, while CRM activity can continue to shape the audience and media experience.
Closing that gap depends on reliably recognizing the same physician across environments, which is what makes CRM signals usable inside a media plan in the first place. Doing that responsibly also requires privacy-safe identity resolution and data-governance controls that keep physician-level data usable while limiting unnecessary exposure of the underlying data.
The more important question is whether what the brand already knows about a physician can change how that physician is reached. The first question is about targeting. The second is about building a media system that can learn.
Measurement Should Feed the Audience, Not Just the Report
Many media programs still treat measurement as the final stage: campaign runs, data is collected, a report is produced, the team reviews what happened.
The real value of measurement emerges when the answer changes what happens next. If certain physician segments show stronger downstream behavior after exposure, does that finding shape future prioritization? If exposure can be connected to NPI-level activity, does that make its way back into planning?
If the answer is no, measurement may be proving performance without improving the system. The strongest audience infrastructure creates a loop: data informs activation, activation generates signals, signals create learning, and learning reshapes the audience.
That loop is much harder to replicate than access to a list.
Audience access can often be rented. A competitor may be able to buy access to the same physician universe. What is much harder to replicate is the audience intelligence, measurement history, engagement signals, and reasoning behind prior decisions that a brand has built over time.
Pharma Brands Should Own the Learning
This leads to the most important implication. Pharma companies should think about audience infrastructure as a corporate asset, not a campaign input.
Brands routinely change agencies, platforms, data partners, and campaign structures, sometimes strategically, sometimes for reasons unrelated to marketing at all. Those changes shouldn’t require an organization to relearn what it already knows about its customers.
Audience definitions, measurement logic, engagement history, and the reasoning behind prior decisions should be durable enough to survive a change in operating model. Otherwise, every transition resets part of the learning process.
A brand that preserves that intelligence can build on previous campaigns. A brand that repeatedly rebuilds it may become highly sophisticated at execution while remaining immature at learning.
The Audience Is the Starting Point
None of this makes audience quality less important. The right audience remains the foundation of effective pharma media.
In categories like rare disease, where the eligible population is small and identification itself can be difficult, audience access may still be the harder problem to solve.
But foundations are rarely where competitive advantage resides once everyone can build one. The next era of pharma media will be defined less by who has access to the audience and more by who builds the strongest system around it.
The audience tells you who matters. The infrastructure determines whether everything a brand learns about that audience makes the next decision better.
___________________________________________________________________________________________________
Patrick Thornton is an enterprise growth leader specializing in paid digital media, AdTech, AI, and healthcare.
If you're navigating paid digital media and interested in connecting, feel free to reach out directly at patrick@patrickthornton.co
